Clinical Trial Update: Montelukast for Patients With Obstructive Sleep Apnea Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial of montelukast for obstructive sleep apnea was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• Montelukast (Montelukast)

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Sleep Apnea, Obstructive | Phase 3 | Status: TERMINATED